Compare Cadila Healthcare with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs WOCKHARDT - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

WOCKHARDT 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE WOCKHARDT CADILA HEALTHCARE/
WOCKHARDT
 
P/E (TTM) x 29.4 -45.9 - View Chart
P/BV x 3.5 1.0 345.4% View Chart
Dividend Yield % 1.0 0.0 25,887.7%  

Financials

 CADILA HEALTHCARE   WOCKHARDT
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-19
WOCKHARDT
Mar-18
CADILA HEALTHCARE/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs4321,012 42.7%   
Low Rs306532 57.6%   
Sales per share (Unadj.) Rs128.6355.9 36.1%  
Earnings per share (Unadj.) Rs18.5-60.3 -30.8%  
Cash flow per share (Unadj.) Rs24.4-46.8 -52.2%  
Dividends per share (Unadj.) Rs3.500.01 35,000.0%  
Dividend yield (eoy) %0.90 73,122.0%  
Book value per share (Unadj.) Rs101.5257.8 39.4%  
Shares outstanding (eoy) m1,023.74110.63 925.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.92.2 132.4%   
Avg P/E ratio x19.9-12.8 -155.6%  
P/CF ratio (eoy) x15.1-16.5 -91.8%  
Price / Book Value ratio x3.63.0 121.6%  
Dividend payout %18.90 -113,751.4%   
Avg Mkt Cap Rs m378,17085,379 442.9%   
No. of employees `00012.46.3 198.9%   
Total wages/salary Rs m21,2419,371 226.7%   
Avg. sales/employee Rs Th10,585.06,295.0 168.1%   
Avg. wages/employee Rs Th1,707.81,498.3 114.0%   
Avg. net profit/employee Rs Th1,526.5-1,066.3 -143.2%   
INCOME DATA
Net Sales Rs m131,65639,369 334.4%  
Other income Rs m2,0111,202 167.3%   
Total revenues Rs m133,66740,571 329.5%   
Gross profit Rs m29,73118 162,464.5%  
Depreciation Rs m5,9861,495 400.3%   
Interest Rs m1,9352,555 75.7%   
Profit before tax Rs m23,821-2,830 -841.9%   
Minority Interest Rs m4690-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,582 0.0%   
Tax Rs m5,303257 2,063.4%   
Profit after tax Rs m18,987-6,669 -284.7%  
Gross profit margin %22.60 48,581.6%  
Effective tax rate %22.3-9.1 -245.1%   
Net profit margin %14.4-16.9 -85.1%  
BALANCE SHEET DATA
Current assets Rs m84,98133,796 251.5%   
Current liabilities Rs m73,42526,917 272.8%   
Net working cap to sales %8.817.5 50.2%  
Current ratio x1.21.3 92.2%  
Inventory Days Days7579 93.9%  
Debtors Days Days11089 122.7%  
Net fixed assets Rs m133,49339,664 336.6%   
Share capital Rs m1,024553 185.1%   
"Free" reserves Rs m102,83927,968 367.7%   
Net worth Rs m103,86328,522 364.2%   
Long term debt Rs m39,49721,731 181.8%   
Total assets Rs m234,83181,620 287.7%  
Interest coverage x13.3-0.1 -12,379.8%   
Debt to equity ratio x0.40.8 49.9%  
Sales to assets ratio x0.60.5 116.2%   
Return on assets %8.9-5.0 -176.8%  
Return on equity %18.3-23.4 -78.2%  
Return on capital %18.3-7.7 -238.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m48,4049,807 493.6%   
Fx outflow Rs m11,5931,789 648.2%   
Net fx Rs m36,8118,019 459.1%   
CASH FLOW
From Operations Rs m28,823684 4,211.4%  
From Investments Rs m-57,3876,302 -910.6%  
From Financial Activity Rs m18,846-7,695 -244.9%  
Net Cashflow Rs m-7,105-664 1,070.0%  

Share Holding

Indian Promoters % 74.8 74.5 100.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 2.3 360.9%  
FIIs % 5.9 7.7 76.6%  
ADR/GDR % 0.0 0.1 -  
Free float % 11.0 15.4 71.4%  
Shareholders   44,069 67,757 65.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  SUVEN LIFESCIENCES  ALEMBIC PHARMA  GLENMARK PHARMA  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 143 Points Lower; Banking and Finance Stocks Witness Selling(Closing)

Indian share markets witnessed selling pressure throughout the day today, tracking weak global cues as coronavirus cases continue to surge across the world.

Related Views on News

WOCKHARDT Announces Quarterly Results (3QFY20); Net Profit Up 125.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

A Warning for Traders: Don't Get Addicted to Hopium(Fast Profits Daily)

Jun 30, 2020

If you are a trader, you must watch out for this dangerous addiction.

Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jul 10, 2020 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS